Clinical Trials Sponsored by Grupo Espanol de Tumores Neuroendocrinos

Total 166 results

Grupo Español de Investigación en Neurooncología

Completed

Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

Glioblastoma

Spain
Grupo Español de Investigación en Neurooncología

Unknown

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Glioblastoma
Grupo Español de Rehabilitación Multimodal
REDGERM; Sociedad Española de Cirugía de la Obesidad

Unknown

Postoperative Outcomes Within an Enhanced Recovery After Bariatric Surgery Protocol (POWER3)

Postoperative Complications | Bariatric Surgery Candidate | Perioperative Care

Spain
Grupo Español de Tratamiento de Tumores de Cabeza...
Amgen; Trial Form Support S.L.

Completed

Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer (VECTITAX)

Head and Neck Cancer

Spain
Grupo Español de Investigación en Neurooncología

Completed

Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma (GEINOGLAS)

Glioblastoma

Spain
Grupo Espanol de Investigacion en Sarcomas
Bayer

Completed

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (REGISTRI)

Gastrointestinal Stromal Tumors

Spain, France, Italy
Grupo Espanol de Investigacion en Sarcomas
GlaxoSmithKline

Completed

Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial

Advanced and / or Metastatic Liposarcoma

Spain, Germany
Grupo Español de Investigación en Neurooncología

Completed

Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.

Glioblastoma

Spain
Grupo Español Multidisciplinar de Melanoma
MFAR

Withdrawn

Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma (CEDUVEAL-M)

Metastatic Cancer | Uveal Melanoma

Spain
Grupo Español de Investigación en Neurooncología

Completed

Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma

Glioblastomas

Spain
Grupo Español de Tumores Huérfanos e Infrecuentes
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study (GREKO III)

Ovarian Cancer

Spain
Grupo Español de Investigación en Cáncer de Ovario

Recruiting

DOstarlimab in Patients With Recurrent or dMMR/MSI-H Endometrial Cancer (DORA)

Endometrial Cancer

Spain
Grupo Español de Tratamiento de Tumores de Cabeza...
Merck Sharp & Dohme LLC; Pivotal S.L.

Terminated

Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy (EXTAX)

Head and Neck Cancer
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

CAR-T Cell Therapy in Patients With Hematological Malignancies

CART Therapy

Spain
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Aspergillus PCR Early Detection in High Risk Oncohematological Patients (PCRAGA)

Infections

Spain
Grupo Espanol de trasplantes hematopoyeticos y...

Active, not recruiting

Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease

Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)

Spain
Grupo Español de Tratamiento de Tumores de Cabeza...
Bristol-Myers Squibb; Apices Soluciones S.L.

Active, not recruiting

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX) (NIVOTAX)

Recurrent Head and Neck Squamous Cell Carcinoma | Head and Neck Cancer Stage IV

Spain
Grupo Español de Investigación en Neurooncología
Pfizer

Completed

Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma Multiforme (Grade IV) of Cerebellum

Spain
Grupo Español de Investigación en Neurooncología
Pfizer

Completed

Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.

Glioblastoma | Brain Tumor, Recurrent

Spain
Grupo Espanol de trasplantes hematopoyeticos y...

Not yet recruiting

Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers

CMV
Grupo Espanol de trasplantes hematopoyeticos y...

Unknown

Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH

Allogeneic Stem Cell Transplantation
Grupo Español de Investigación en Cáncer de Ovario

Completed

Retrospective Multicenter Study of Elderly Patients With Ovarian Cancer Treated With Trabectedin and PLD

Ovarian Cancer

Spain
Grupo Español de Investigación en Cáncer de Ovario

Completed

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

Spain
Grupo Español de Investigación en Cáncer de Ovario

Completed

Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer

Platinum-resistant Advanced Ovarian Cancer

Spain
Grupo Español de Investigación en Neurooncología
Pfizer

Completed

Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved

Oligoastrocytoma | Oligodendroglioma

Spain
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT (BUFLU)

Acute Myeloid Leukemia | Myeloproliferative Disorders | Chronic Myeloid Leukemia | Myelodysplastic Syndrome
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia (DASA-TRAS)

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Spain
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. (CSM/EICH2010)

Chronic Graft-Versus-Host Disease

Spain
Grupo Español de Investigación en Cáncer de Ovario
PharmaMar

Completed

Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC (RETRO-ROC)

Ovarian Epithelial Cancer Recurrent
Grupo Español Multidisciplinar de Melanoma
Bristol-Myers Squibb

Completed

GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases (GRAY-B)

Melanoma | Brain Metastases

Spain
Grupo Español de Investigación en Cáncer de Ovario
AstraZeneca

Completed

Resistant Ovarian Cancer, Olaparib and Liposomal Doxorubicin (ROLANDO)

Advanced Ovarian Cancer

Spain
Grupo Espanol de trasplantes hematopoyeticos y...
GlaxoSmithKline

Completed

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation

Chronic Lymphocytic Leukemia

Spain
Grupo Español Multidisciplinar de Melanoma
Bristol-Myers Squibb

Completed

Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma (GEM1402)

Uveal Melanoma

Spain
Grupo Español de Rehabilitación Multimodal
GRACE Group; REDGERM

Unknown

Postopoperarive Outcomes After Colorectal Surgery in Europe (euroPOWER) (EuroPOWER)

Postoperative Complications | Colorectal Surgery | Perioperative Care

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Recruiting

Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis (CAVI_CU)

IBD-Inflammatory Bowel Disease | UC - Ulcerative Colitis

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Recruiting

Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease. (ENDOCIR)

Crohn Disease

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Active, not recruiting

Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU (M-TECCU)

Crohn's Disease | Ulcerative Colitis | Telemedicine | Inflammatory Bowel Disease

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Unknown

Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease (PROTDILAT)

Crohn's Disease | Chronic Inflammation | Stenosis

Spain
Groupe Oncologie Radiotherapie Tete et Cou
AIO-Studien-gGmbH; Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Completed

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC (TPExtreme)

Head and Neck Squamous Cell Carcinoma

France, Germany, Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Terminated

Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis (ATICCA)

Ulcerative Colitis

Spain, Portugal, Austria, Italy, Germany
Grupo Español de Linfomas y Transplante Autólogo...

Completed

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

B-Cell Lymphomas

Spain
Grupo Español de Linfomas y Transplante Autólogo...

Unknown

Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT (MAN2)

Mantle-cell Lymphoma

Spain
Grupo Español de Linfomas y Transplante Autólogo...

Terminated

Cyclosporine Plus Methotrexate or Alemtuzumab

Unrecognized Condition: Mature B or T-cell Neoplasm

Spain, Poland
Grupo Español de Linfomas y Transplante Autólogo...

Completed

Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL) (Z-RIC-Allo)

Non-Hodgkin Lymphoma

Spain
Grupo Español de Linfomas y Transplante Autólogo...

Completed

Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma

Hodgkin Disease

Spain
Grupo Español de Linfomas y Transplante Autólogo...

Completed

Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma (R-MEGACHOP)

Diffuse Large B-cell Lymphoma | Follicular Grade 3B Lymphoma

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Not yet recruiting

Immunological Characteristics of Preclinical IBD(EARLY) (EARLY)

Crohn Disease | Ulcerative Colitis | IBD

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Completed

Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis (CECUM)

Ulcerative Colitis

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Completed

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease (INFEII)

Inflammatory Bowel Diseases

Spain
Grupo Español de Linfomas y Transplante Autólogo...

Completed

R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial

Non-Hodgkin's Lymphoma

Spain

Clinical Trials Sponsored by Grupo Espanol de Tumores Neuroendocrinos

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations